Writing in a linked Comment, Dr Pratik Choudhary from King's College London, UK, says,» OpT2mise provides a compelling case for
the clinical effectiveness of insulin pump treatment in type 2 diabetes, suggesting that it can help improve glycaemic control in this difficult to treat group of patients who are unable to achieve glucose control despite increasing doses of insulin.